Crocetin inhibits leukocyte adherence to vascular endothelial cells induced by AGEs

Journal of Ethnopharmacology

Volumn 107, Issue 1, 2006, Pages 25-31

  Xiang, Min ^a   Qian, Zhi Yu ^a   Zhou, Cheng Hua ^a   Liu, Juan ^b   Li, Wen Na ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

^c Department of Pharmacology   (China)

Author keywords

Adhesion; Advanced end products (AGE); Crocetin; Intercellular adhesion molecule 1 (ICAM 1); Oxidative stress

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADVANCED GLYCATION END PRODUCT; ANION; ANTIOXIDANT; CROCETIN; INTERCELLULAR ADHESION MOLECULE 1; MALONALDEHYDE; MYELOPEROXIDASE; OXYGEN; RHODAMINE 123; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ASSAY; CELL GROWTH; CELL LEVEL; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; EXPOSURE; GROWTH INHIBITION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; LEUKOCYTE ADHERENCE; LEUKOCYTE ADHERENCE INHIBITION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PREVENTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UPREGULATION; VASCULAR ENDOTHELIUM;

CAROTENOIDS; CELL ADHESION; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALONDIALDEHYDE; MEMBRANE POTENTIALS; MITOCHONDRIA; SUPEROXIDE DISMUTASE; SUPEROXIDES;

BOS TAURUS;

EID: 33745843700     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.01.022     Document Type: Article

References (37)

1. Ahmad A.S., Ansari M.A., Ahmad M., Saleem S., Yousuf S., Hoda M.N., and Islam F. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacology, Biochemistry and Behavior 81 (2005) 805-813
2. Armando R., and Miguel A.M. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sciences 76 (2004) 715-730
3. Bath P.M.W., Booth R.F.G., and Hassal D.G. Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. Journal of Immunological Methods 118 (1989) 59-65
4. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D.M., Schmidt A.M., and De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105 (2002) 816-822
5. Basta G., Schmidt A.M., and De C.R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research 63 (2004) 582-592
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
7. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26 (2003) 1589-1596
8. Chen C.C., Chou C.Y., Sun Y.T., and Huang W.C. Tumor necrosis factor α-induced activation of downstream NF-κB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: Involvement of PKCα, tyrosine kinase, and IKK2, but not MAPKs pathway. Cellular Signalling 13 (2001) 543-553
9. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., and Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. The Journal of biological chemistry 278 (2003) 36027-36031
10. Chow F.Y., Nikoloic-Paterson D.J., Ozols E., Atkins R.C., and Tesch G.H. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. Journal of the American Society of Nephrology 16 (2005) 1711-1722
11. Elhadd T.A., Kennedy G., Robb R., McLaren M., Jung R.T., and Belch J.J.F. Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease. International Angiology 23 (2004) 128-133
12. Gerrity R.G. The role of monocytes atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology 103 (1981) 181-190
13. Gong G., Liu T., and Li L. Antioxidative activity of crocetin in vitro. Journal of China Pharmaceutical University 32 (2001) 306-309
14. Hong H., and Liu G.Q. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sciences 74 (2004) 2959-2973
15. Kunt T., Forst T., Wilhelm A., Zschabitz A., Gopfert A., Kann P., Pfuetzner A., Harzer O., Engelbach M., Beyer J., and Stofft E. Establishment of a quantitative RT-PCR for detection of vascular cell adhesion molecule-1 transcripts in endothelial cells after stimulation with advanced glycation end products. International Journal of Molecular Medicine 2 (1998) 455-460
16. ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. Journal of biological Chemistry 272 (1997) 17810-17814
17. Lee I.A., Lee J.H., Baek N.I., and Kim D.H. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin. Biological and Pharmaceutical Bulletin 28 (2005) 2106-2110
18. Li W., and Qian Z.-Y. Effect of crocetin on cardiotaxicity of doxorubicin in rats. Chinese Journal of New Drugs 14 (2005) 1165-1169
19. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
20. Marie-Paule W., Oliver C., Stefano C., Davidm S., Annmarie S., and Jean-Luc W. Activation of NAPDH oxidase by AGEs links oxidant stress to altered gene expression via RAGEs. American Journal of Physiology-Endocrinology and Metabolism 280 (2001) E685-E694
21. Pagé M., Bejaoui N., Cinq-Mars B., and Lemieux P. Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. International Journal of Immunopharmacology 10 (1988) 785-793
22. Ristow M., Pfister M.F., Yee A.J., Schubert M., Michael L., Zhang C.Y., Ueki K., Michael II M.D., Lowell B.B., and Kahn C.R. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proceedings of the National Academy of Sciences 97 (2000) 12239-12243
23. Roebuck K.A., and Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. Journal of Leukocyte Biology 66 (1999) 876-888
24. Ruderman N.B., Willianmson J., and Brownlee B. Glucose and diabetic vascular disease. FASEB Journal 6 (1992) 2905-2914
25. Seikoh H., Norie A., and Yoshimasa M. Immunochemical approach to characterize advanced glycation end products of the mail and reaction: evidence for the presence of a common structure. Journal of Biological Chemistry 266 (1991) 7329-7332
26. Shi F.Y., Ravichandran Y., and Ann M.S. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circulation Research 93 (2003) 1159-1169
27. Shinichi O., Kenichi S., Mitsuhiro M., Daisuke O., Hitomi U., Yuichi K., Ryo N., Jun W., Yasushi S., and Hirofumi M. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52 (2003) 2586-2593
28. Staunton D.E., Marlin S.D., Stratowa C., Dustin M.L., and Springer T.A. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52 (1988) 925-933
29. Tara C.B.M., Jonathan E.M., Yuichi K., Norma F., Tomohiko U., Vasiliki P., Iain L.C., Alan W.S., Tom A.G., Desmond B.A., and Anthony P.A. The role of advanced glycation end products in retinal microvascular leukostasis. Investigative Ophthalmology and Visual Science 44 (2003) 4457-4464
30. Tseng T.H., Chu C.Y., Huang J.M., Shiow S.J., and Wang C.J. Crocetin protects against oxidative damage in rat primary hepatocytes. Cancer Letter 97 (1995) 61-67
31. Turrens J.F. Mitochondrial formation of reactive oxygen species. Journal of Phycology 552 (2003) 335-344
32. Wang C.J., Shiow S.J., and Lin J.K. Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats. Carcinogenesis 12 (1991) 459-462
33. Wang C.J., Cheng T.C., Liu J.Y., Chou F.P., Kuo M.L., and Lin J.K. Inhibition of protein kinase C and proto-oncogene expression by crocetin in NIH/3T3 cells. Molecular Carcinogenesis 17 (1996) 235-240
34. Xi L., Qian Z.-Y., Shen X., Wen N., and Zhang Y. Crocetin prevents dexamethasone-induced insulin resistance in rats. Planta Medica 71 (2005) 917-922
35. Xu G., and Qian Z.-Y. Protective effect of crocin-1 on bovine aortic endothelial cells. Chinese Traditional and Herbal Drugs 33 (2002) 439-442
36. Yuicbi K., Sbiro A., and Tomobiko U. Expression and function of receptor for advanced glycation end products in bovine corneal endothelial cells. Investigative Ophthalmology and Visual Science 44 (2003) 521-528
37. Zheng S., Qian Z.-Y., and Tang F. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochemical Pharmacology 70 (2005) 1192-1199